Class I--restricted T cell--associated molecule (Crtam) is an Ig-like cell surface protein that was originally found on activated NKT cells ([@bib19]), NK cells, and CD8^+^ T cells ([@bib1]; [@bib3]; [@bib11]) and shown to bind the cell adhesion molecule 1 (Cadm1, also known as Nectin like \[Necl\] 2; [@bib1]; [@bib3]; [@bib11]). Cadm1 is a cell surface molecule of the nectin and Necl families that is expressed on CD8α DCs ([@bib11]; [@bib29]), epithelial cells, neurons, and tumor cells ([@bib31]; [@bib23]). Crtam--Cadm1 interactions strengthen NK cell and CD8^+^ T cell effector functions ([@bib1]; [@bib3]; [@bib11]; [@bib27]) and promote the retention of virus-specific CD8^+^ T cells within LNs ([@bib38]). One report proposed that Crtam is essential for the establishment of CD4^+^ T cell polarization after TCR engagement, a process which blocks CD4^+^ T cell division and induces the capacity to secrete IFN-γ, IL-17, and IL-22 ([@bib41]).

The immune system associated with the gastrointestinal mucosa comprises large numbers of dispersed lymphoid cells that reside in the epithelium and the underlying lamina propria. Intraepithelial lymphocytes (IELs) and lamina propria lymphocytes (LPLs) include antigen-experienced CD8^+^ and CD4^+^ T cells, γδ T cells, various subsets of innate lymphoid cells (ILCs), and IgA-secreting plasma cells ([@bib16]; [@bib5]; [@bib6]; [@bib34]; [@bib36]). Homing and residency of IELs and LPLs in the mucosa requires specialized chemokine receptors, such as CCR9, CCR6, and CXCR6, which detect chemokines released by gut epithelial cells (CCL25, CCL20, and CXCL16, respectively; [@bib18]). Integrins, like CD103 (α~E~) and α~4~β~7~, also play an essential role in promoting homing and retention of IELs and LPLs in the mucosa by binding E-cadherin and MAdCAM-1 on epithelial cells and vascular endothelial cells, respectively ([@bib18]).

T cell acquisition of homing and adhesion molecules is induced by T cell interaction with DCs ([@bib24]; [@bib40]). Among the disparate subsets of DC in the intestinal lamina propria and mesenteric LNs (mLN), the CD103^+^ DC subset produces retinoic acid (RA), which induces the gut homing receptors CCR9 and α~4~β~7~ on lymphocytes ([@bib7]; [@bib24]; [@bib40]). Gut-associated CD103^+^ DCs also produce TGF-β, which induces the expression of CD103 on T cells ([@bib7]; [@bib24]; [@bib40]). In addition to imprinting gut-homing capacity on T cells, gut CD103^+^ DCs control the differentiation of CD4^+^ T cells by priming regulatory CD4^+^ T cells during the steady state ([@bib25]) and TH1 and TH17 cells during inflammation ([@bib8]; [@bib15]).

Here, we investigated the impact of Crtam--Cadm1 interaction in the intestinal immune system. We find that Crtam is expressed upon activation on all CD8^+^ T cells of the intestinal mucosa and mLN, intraepithelial CD4^+^ T cells, and intraepithelial CD4^+^CD8^+^ T cells, whereas Cadm1 is expressed on gut CD103^+^ DCs. Crtam--Cadm1 interactions have a major impact on the maintenance of intraepithelial CD4^+^CD8^+^ T cells and a limited influence on the presence of mucosal CD4^+^ and CD8^+^ T cells. *Crtam*^−/−^ and *Cadm1*^−/−^ mice almost completely lacked CD4^+^CD8^+^ T cells in the intestinal epithelium under steady-state conditions and had fewer CD4^+^ and CD8^+^ T cells in the intestinal mucosa than WT mice. CD4^+^CD8^+^ T cells arise from CD4^+^ T cells that acquire a CD8 T cell lineage gene expression profile upon reaching the intestinal mucosa ([@bib26]; [@bib30]). Therefore, we further investigated the role of Crtam--Cadm1 interactions in governing CD4^+^ T cell homing and maintenance in the intestinal mucosa, and found that *Crtam*^−/−^ CD4^+^ T cells reconstituted the intestinal CD4^+^ T cell and CD4^+^CD8^+^ T cell subsets less effectively than did WT CD4^+^ T cells after transfer into *Rag1*^−/−^ mice. Moreover, fewer intestinal CD4^+^ T cells in *Crtam*^−/−^ mice expressed gut homing, adhesion, and retention molecules typical of their counterparts in WT mice (including CCR9, CD103, and CD69), and hence adhered less firmly to the intestinal mucosa.

Crtam deficiency did not affect the intrinsic capacity of naive CD4^+^ T cells to differentiate into IFN-γ-- or IL-17--producing CD4^+^ T cells in vitro. After acute oral infection with *Toxoplasma gondii*, both WT and *Crtam*^−/−^ mice mounted a robust TH1 response and cleared the intestinal infection. However, a preferential reduction of TH17 cells was evident within the intestinal mucosa CD4^+^ T cells in the *Crtam*^−/−^ mice. The almost exclusive TH1 response in *Crtam*^−/−^ mice resulted in more efficient clearance of intestinal infection. Antibody blockade of IL-17 in WT mice orally infected with *T. gondii* recapitulated the enhanced host response of *Crtam*^−/−^ mice. Thus, the defects in T cell gut homing and maintenance in *Crtam*^−/−^ mice preferentially affected TH17, whereas TH1 were relatively unaffected. Because the differentiation of CD4^+^CD8^+^ T cells from CD4^+^ T cells skews CD4^+^ T cell cytokine production toward IFN-γ at the expenses of IL-17 production ([@bib26]; [@bib30]), the need for continuous replacement of lost CD4^+^CD8^+^ T cells in *Crtam*^−/−^ mice may result in a relative depletion of TH17 cells. Together, these results demonstrate that Crtam--Cadm1 interactions have a major impact on the residency and maintenance of CD4^+^CD8^+^ T cells in the gut mucosa in the steady-state. During mucosal responses against pathogenic infection, Crtam--Cadm1 interactions may be required to retain a balanced representation of disparate CD4^+^ T cell subsets, thereby influencing the overall quality of the CD4^+^ T cell response.

RESULTS AND DISCUSSION
======================

*Crtam*^−/−^ and *Cadm1*^−/−^ mice have markedly fewer CD4^+^CD8^+^ T cells in the intestinal mucosa under steady-state conditions
----------------------------------------------------------------------------------------------------------------------------------

Previous studies showed that mouse Crtam is expressed on the surface of recently activated CD8^+^ T cells and NK cells ([@bib1]; [@bib3]; [@bib38]) as well as on a subset of activated CD4^+^ T cells ([@bib41]). We asked whether Crtam is expressed on T cells in the intestinal mucosa and mLN. All gut T cells expressed very low to undetectable amounts of Crtam ex vivo. Upon stimulation in vitro, robust expression of Crtam was detected on CD8^+^ T cells from all tissues examined, including intestinal epithelium and lamina propria, Peyer's Patches, and mLN ([Fig. 1 A](#fig1){ref-type="fig"}). In contrast, only activated CD4^+^ T cells from the intestinal epithelium strongly expressed Crtam. Intraepithelial CD4^+^CD8^+^ T cells also expressed high levels of Crtam, consistent with the recent detection of Crtam mRNA in these cells ([@bib26]).

![**CRTAM and its ligand are expressed in intestinal T cells and CD103^+^ DC, respectively.** (A) Frequency of Crtam^+^ T cells from different tissues 14 h after stimulation with anti-CD3 and -CD28. (B) Frequency of mCRTAM-hFc^+^ cells within the CD103^+^ (1), the CD103^+^CD11b^+^ (2), and the CD11b^+^ (3) subsets of CD11c^+^MHCII^+^ DCs in the mLN and siLPL of WT and *Cadm1*^−/−^ mice. All data are representative of two independent experiments.](JEM_20130904_Fig1){#fig1}

Cadm1, the ligand of Crtam, is expressed on epithelial cells ([@bib31]; [@bib27]; [@bib23]) and CD8α DCs ([@bib11]; [@bib29]), yet the distribution of Cadm1 in the intestinal mucosa has not been determined. To address this, we stained the LPLs from the small intestine and the mLNs with a fusion protein consisting of the extracellular domain of murine Crtam and the Fc portion of human IgG1 (mCrtam-hFc). We found that mCrtam-hFc bound CD11c^+^ MHCII^+^ DCs, particularly the CD103^+^ DC subset ([Fig. 1 B](#fig1){ref-type="fig"}). The binding of mCrtam-hFc to gut CD103^+^ DC was abrogated in *Cadm1*^−/−^ mice ([@bib39]), indicating that Cadm1 is the bona fide ligand of Crtam in the intestine ([Fig. 1 B](#fig1){ref-type="fig"}). Although we observed no binding of mCrtam-hFc to intestinal epithelial cells (unpublished data), the amount of Cadm1 expressed on primary epithelial cells may be too low to be detected with an Fc fusion protein. It is also possible that binding of mCrtam-hFc to Cadm1 on epithelial cells is blocked by the homotypic or heterotypic interactions that Cadm1 establishes with other Nectins and Necls in cis and in trans ([@bib21]).

To investigate the functional impact of Crtam on intestinal mucosa T cells, we generated *Crtam*^−/−^ mice ([Fig. S1](http://www.jem.org/cgi/content/full/jem.20130904/DC1){#supp1}). Analysis of small intestine IELs and LPLs revealed a partial reduction of CD8^+^ T cells and CD4^+^ T cells in naive *Crtam*^−/−^ mice compared with WT mice ([Fig. 2, A--D](#fig2){ref-type="fig"}). Furthermore, the lack of Crtam preferentially affected double-positive CD4^+^CD8^+^ T cells, which were almost absent, particularly in the epithelium ([Fig. 2, A--D](#fig2){ref-type="fig"}). Percentages of intestinal γδ T cells and intraepithelial ILC1 were similar in *Crtam*^−/−^ and WT mice ([Fig. 2, E and F](#fig2){ref-type="fig"}). Crtam deficiency did not affect the presence of CD4^+^ or CD8^+^ T cells in the spleen (unpublished data), confirming previous data obtained with other *Crtam*^−/−^ mouse strains ([@bib41]; [@bib38]). Altogether, these data suggest that Crtam is essential for the presence of mucosal CD4^+^CD8^+^ T cells and is partially required for intraepithelial and lamina propria CD8^+^ T cells and CD4^+^ T cells in the steady state.

![**T cells in the small intestine are reduced in *Crtam*^−/−^ and *Cadm1*^−/−^ mice.** (A--D) Representative plots and total cell numbers of CD8^+^ T cells (gated on CD45^+^ cells), CD4^+^ T cells (gated on CD45^+^ cells), and CD4^+^CD8^+^ T cells (gated on CD3^+^CD45^+^) from the siIEL (A and C) and siLPL (B and D) of WT, *Crtam*^−/−^, and *Cadm1*^−/−^ mice. (E--F) Frequencies of γδ T cells (gated on CD8^+^CD3^+^; E) and ILC1 (gated on CD3^−^; F) in the siIEL and siLPL of WT and *Crtam*^−/−^ mice. (G) Representative plots and frequencies of CD8^+^ T cells, CD4^+^ T cells, and CD4^+^CD8^+^ T cells from the siIEL of WT and *Batf3*^−/−^ mice. Data are representative of pooled mice from at least four (A--D) and two (E--G) independent experiments. Statistical analysis was performed using Mann-Whitney test for cell numbers and Student's *t* test for frequencies (ns = not significant; \*, P \< 0.05; \*\*, P ≤ 0.01; \*\*\*, P ≤ 0.001). Horizontal bars show medians. Error bars are SEM.](JEM_20130904R_Fig2){#fig2}

Analysis of IELs and LPLs from *Cadm1*^−/−^ mice revealed a phenotype strikingly similar to that of *Crtam*^−/−^ mice, distinguished by the partial reduction of CD8^+^ and CD4^+^ T cells and the near absence of CD4^+^CD8^+^ T cells ([Fig. 2, A--D](#fig2){ref-type="fig"}). Because Crtam is robustly induced on activated IEL and LPL T cells and Cadm1 is constitutively expressed on intestinal CD103^+^ DCs, we hypothesize that Crtam--Cadm1 interactions govern homing and/or retention of intestinal mucosa T cells. Supporting this notion, *Batf3*^−/−^ mice, which lack CD103^+^ DC ([@bib9]), also showed a strong reduction of intraepithelial CD4^+^CD8^+^ T cells ([Fig. 2 G](#fig2){ref-type="fig"}). The strict expression pattern of Crtam only on intraepithelial CD4^+^ T cells, as well the dramatic reduction of CD4^+^CD8^+^ T cells, which are derived from CD4^+^ T cells upon arrival in the intestinal mucosa ([@bib26]; [@bib30]), persuaded us to further study the role of Crtam specifically in these cells.

Crtam deficiency affects CD4^+^ T cell acquisition of molecules for homing and retention in the intestine
---------------------------------------------------------------------------------------------------------

We asked whether Crtam--Cadm1 interaction imprints gut-homing capacity on CD4^+^ T cells. To test this hypothesis, we performed a competitive adoptive transfer in which purified T cells from WT (CD45.1) and *Crtam*^−/−^ (CD45.2) mice were injected into *Rag1*^−/−^ mice at a 1:1 ratio and given 8 wk to reconstitute the small intestine. WT T cells outcompeted *Crtam*^−/−^ T cells in both the siIEL and siLPLs by frequencies of 60 to 40% for CD4^+^ T cells and 70 to 30% for CD4^+^CD8^+^ T cells ([Fig. 3 A](#fig3){ref-type="fig"}). To determine whether defective homing/retention is paralleled by defective acquisition of effector functions, we recovered siIEL and siLPL CD4^+^ T cells from reconstituted *Rag1*^−/−^ mice and assessed their cytokine production. We detected no difference in the ability of CD4^+^ T cells to produce IL-17 or IFN-γ ex vivo, suggesting that there was no defect in T cell priming in these settings ([Fig. 3 B](#fig3){ref-type="fig"}).

![***Crtam*^−/−^ CD4^+^ T cells have dysfunctional gut homing and retention properties but normal cytokine production.** (A) Purified splenic T cells from WT (CD45.1) and *Crtam*^−/−^ (CD45.2) mice were mixed at 1:1 ratio and transferred i.v. into *Rag1*^−/−^ mice. Plots and bar graphs show the frequencies of CD45.2 versus CD45.1 within the CD4^+^ and CD4^+^CD8^+^ T cells (gated on CD45^+^CD3^+^ cells) in the siIEL and siLPL 8 wk after transfer. (B) Intracellular content of IL-17 and IFN-γ in the siIEL and siLPL recovered from the competitive adoptive transfer in A. (C) T cell adherence was analyzed in the siIEL of WT and *Crtam*^−/−^ mice by a sequential gentle then stringent isolation. Percentages of CD4^+^ and CD4^+^CD8^+^ T cells in the loose fraction (gentle isolation) of the small intestine are shown. (D) Frequency of CD4^+^ T cells expressing CD103, CD69, and CCR9 in the siIEL and siLPL of WT and *Crtam*^−/−^ mice. Data represent two (A and B) and at least three (C and D) independent experiments. Statistical analysis was performed using Student's *t* test (\*, P ≤ 0.05; \*\*, P ≤ 0.01; \*\*\*, P ≤ 0.001). Error bars are SEM.](JEM_20130904_Fig3){#fig3}

To directly test the impact of Crtam on the retention of T cells in the gut, we performed a recently developed method for isolation that distinguishes IELs as either loosely or tightly attached to the intestinal mucosa ([@bib42]). We found that the fraction of loosely attached CD4^+^ T cells and CD4^+^CD8^+^ T cells was significantly higher in *Crtam*^−/−^ mice than WT mice ([Fig. 3 C](#fig3){ref-type="fig"}). Intraepithelial CD4^+^ T cells and CD4^+^CD8^+^ T cells express CD103, which facilitates their retention in the epithelium ([@bib32]; [@bib4]; [@bib42]). They also highly express CD69, which is thought to prevent their exit from the mucosa ([@bib35]; [@bib42]). Consistent with their loose interaction with the intestinal mucosa, intestinal CD4^+^ T cells isolated from *Crtam*^−/−^ mice expressed much less CD103 and CD69 on the cell surface than did their counterparts in WT mice ([Fig. 3 D](#fig3){ref-type="fig"}). Moreover, *Crtam*^−/−^ CD4^+^ T cells also expressed less CCR9 in LPLs, which is essential for homing in the gut.

It has been shown that CD103^+^ DCs imprint gut-homing capacity on T cells through the production of RA and TGF-β, which in turn induce CCR9 and CD103 on CD4^+^ T cells ([@bib24]; [@bib40]). In addition, exposure of CD4^+^ T cells to RA and TGF-β in the intestinal mucosa induces CD4^+^ T cells to down-regulate the CD4 T cell lineage profile and acquire a CD8 T cell lineage profile to become CD4^+^CD8^+^ T cells ([@bib26]; [@bib30]). Thus, it is likely that Crtam--Cadm1 interactions promote expression of gut-homing molecules on CD4^+^ T cells as well as the generation of CD4^+^CD8^+^ T cells from CD4^+^ T cells by sustaining the exposure of CD4^+^ T cells to CD103^+^ DCs that produce RA and TGF-β. This mechanism is consistent with the overall reduced adhesiveness of Crtam-deficient T cells to other cells in the intestinal mucosa.

Crtam deficiency selectively impairs the presence of intestinal TH17 cells during *T. gondii* infection
-------------------------------------------------------------------------------------------------------

We sought to determine whether *Crtam*^−/−^ T cells had defects in the capacity to secrete cytokines. A previous study reported that CD4^+^ T cells from *Crtam*^−/−^ mice have an intrinsic defect in producing IFN-γ, IL-17, and IL-22 ([@bib41]). However, we found that naive *Crtam*^−/−^ and WT CD4^+^ T cells stimulated through the TCR and exposed to polarizing cytokines produced equivalent amounts of IFN-γ and IL-17 ([Fig. 4, A--F](#fig4){ref-type="fig"}). Thus, *Crtam*^−/−^ T cells have no intrinsic functional polarization defects in vitro. We next sought to determine whether *Crtam*^−/−^ CD4^+^ T cells have in vivo functional defects that could impact host responses to pathogens. It was reported that *Crtam*^−/−^ mice are susceptible to intestinal infections by *Citrobacter rodentium* ([@bib41]). This pathogen is primarily controlled through secretion of IL-22 by TH17, TH22, and type-3 ILC ([@bib28]; [@bib2]). However, we found that *Crtam*^−/−^ and WT mice were equally resistant to *C. rodentium* infection ([Fig. 4 G](#fig4){ref-type="fig"}).

![***Crtam*^−/−^ CD4^+^ T cells have normal TH1 and TH17 polarization in vitro.** 2 × 10^5^ purified CD4^+^ T cells from LNs of WT or *Crtam*^−/−^ mice were stimulated in vitro under TH1 or TH17 polarizing conditions for 5 d (1°). For restimulation, T cells were recovered and 2 × 10^5^ cells were plated for 2 additional days without polarizing cytokines (2°). IFN-γ and IL-17 production was assessed by intracellular staining: (A and D) representative plots; (B and E) quantification; and (C and F) cytometric bead array of culture supernatants. (G) WT and *Crtam*^−/−^ mice were orally infected with 2 × 10^9^ *C. rodentium* and splenic titers analyzed at days 8 and 16. The CFUs detected in WT at day 16 are insignificant. Data are representative of three (A and B) or two (C) independent experiments. Statistical analysis was performed using Student's *t* test (ND, not detected). Error bars are SD.](JEM_20130904R_Fig4){#fig4}

Because Crtam is expressed on several T cell sources of IFN-γ, such as CD8^+^ T cells, TH1, and CD4^+^CD8^+^ T cells, we investigated the impact of *Crtam* deficiency in the infection by *T. gondii*, an intracellular parasite which is highly sensitive to host IFN-γ ([@bib37]; [@bib12]; [@bib33]; [@bib13]). We infected mice through the oral route using *T. gondii* tissue cysts to directly challenge the small intestine immune system. We used a type II avirulent Prugniaud strain of *T. gondii* expressing a firefly luciferase, so that parasitic replication could be monitored in live mice throughout the infection. After oral infection with *T. gondii*, WT mice had a peak of parasitic replication at day 8--9 post infection (p.i.) followed by clearance at day 14 p.i. ([Fig. 5 A](#fig5){ref-type="fig"}). WT mice lost ∼20% of their initial weight and started to recover weight 5 wk after infection ([Fig. 5 B](#fig5){ref-type="fig"}). In contrast, *Crtam*^−/−^ mice showed minimal or no detectable *T. gondii* replication ([Fig. 5 A](#fig5){ref-type="fig"}) and lost less weight than WT mice during the initial 5 wk of infection ([Fig. 5 B](#fig5){ref-type="fig"}). Thus, *Crtam*^−/−^ mice can control *T. gondii* intestinal infection more effectively than WT mice.

![***Crtam*^−/−^ mice are more resistant to *T. gondii* oral infection due to reduced TH17 response.** WT and *Crtam*^−/−^ mice were orally infected with 5 tissue cysts of *T. gondii* (pru-luc). (A and B) Parasite burden (A) and weight loss (B) were monitored throughout the course of the infection. (C) Numbers of CD8^+^ T cells, CD4^+^ T cells, and CD4^+^ CD8^+^ T cells in the siIEL and siLPL of WT and *Crtam*^−/−^ mice at days 6 and 9 after infection. (D) Gene expression microarray of siIEL CD4^+^ T cells (CD45^+^CD3^+^CD4^+^CD8^−^) from WT and *Crtam*^−/−^ mice at day 8 p.i. The bar graph indicates fold differences in the expression of selected genes of interest between siIEL *Crtam*^−/−^ and WT CD4^+^ T cells. The dashed lines are placed at 2.5-fold difference. (E) Quantitative PCR analysis of gene expression in siIEL CD4^+^ T cells (CD45^+^CD3^+^CD4^+^CD8^−^) 8 d p.i. (F) Intracellular stain for IFN-γ and IL-17 at days 6 and 9 p.i. (G) Quantitative PCR analysis of gene expression in ileum samples at days 6 and 9 p.i. Values are relative to mRNA expression in naive mice. Data (A--C and F--G) are representative of at least three independent experiments. Statistical analysis was performed using Mann-Whitney test for T cell numbers and Student's *t* test for all others (\*, P ≤ 0.05; \*\*, P ≤ 0.01; \*\*\*, P ≤ 0.001). Error bars are SEM.](JEM_20130904_Fig5){#fig5}

We asked why *Crtam*^−/−^ mice have a more effective intestinal immune response to *T. gondii*. Consistent with what we observed in the steady state, severely reduced numbers of CD4^+^CD8^+^ T cells and a partial reduction of CD4^+^ T cells were evident in the IELs and LPLs from the small intestine of *Crtam*^−/*−*^ mice after infection with *T. gondii* ([Fig. 5 C](#fig5){ref-type="fig"}). Because the host response to *T. gondii* infection relies on IFN-γ ([@bib37]; [@bib12]; [@bib33]; [@bib13]) and CD4^+^CD8^+^ T cells secrete IFN-γ, it seemed plausible that the reduction of CD4^+^CD8^+^ T cells in *Crtam*^−/−^ mice would be compensated for by changes in other cytokines such that the overall immune response would be improved. Analysis of the transcriptional profile of total CD4^+^ T cells isolated from the intestine of WT and *Crtam*^−/−^ mice after infection with *T. gondii* by microarray revealed a preferential reduction of IL-17A, IL-17F, and IL-22 in *Crtam*^−/−^ CD4^+^ T cells, whereas IFN-γ, IL-10, and TGF-β were maintained ([Fig. 5 D](#fig5){ref-type="fig"}). Real-time PCR analysis confirmed the reduction in IL-17A, IL-17F, and IL-22, whereas IFN-γ, TGF-β, and IL-10 transcripts were not significantly different in WT and *Crtam*^−/−^ CD4^+^ T cells ([Fig. 5 E](#fig5){ref-type="fig"} and not depicted). This data suggested a preferential reduction of the TH17 response during *T. gondii* infection.

We further investigated the cytokine content of *Crtam*^−/−^ and WT CD4^+^ T cells at days 6 and 9 after *T. gondii* infection by intracellular staining. Both *Crtam*^−/−^ and WT mice had high frequencies of IFN-γ--producing CD4^+^ T cells ([Fig. 5 F](#fig5){ref-type="fig"}), consistent with the notion that *T. gondii* infection induces a robust TH1 cell response ([@bib12]; [@bib33]). IL-17--producing CD4^+^ T cells were less abundant than IFN-γ--producing CD4^+^ T cells and were selectively reduced in *Crtam*^−/−^ mice ([Fig. 5 F](#fig5){ref-type="fig"}). The selective reduction of TH17 in the small intestine of *Crtam*^−/−^ mice resulted in substantial attenuation of IL-17 mRNA in the whole ileum ([Fig. 5 G](#fig5){ref-type="fig"}). Ileal IL-22 mRNA was not noticeably reduced despite decreased IL-22 in the CD4^+^ T cell compartment, suggesting that other cellular sources of IL-22, such as type-3 ILC, may compensate at least in part for the functional defect of *Crtam*^−/−^ CD4^+^ TH17 cells. In *Crtam*^−/−^ mice, because no changes were noted in IFN-γ, which promotes resistance to *T. gondii*, or IL-10 and TGF-β, which modulate resistance to *T. gondii* ([@bib22]; [@bib17]), we hypothesized that the reduced IL-17 production in *Crtam*^−/−^ mice was sufficient to explain the enhanced clearance of *T. gondii*. Indeed, antibody blockade of IL-17A ([Fig. 6](#fig6){ref-type="fig"}) or IL-17A and F (not depicted) in WT mice orally infected with *T. gondii* recapitulated the enhanced parasite clearance observed in *Crtam*^−/−^ mice.

![**IL-17 neutralization in WT mice reduces severity of *T. gondii* infection.** WT mice were injected with isotype control or neutralizing antibodies to IL-17A at days −1, 5, and 10 of infection with *T. gondii*. (A and B) Parasite burden (A) and weight loss (B) were monitored throughout the course of the infection. Data represent two independent experiments. Statistical analysis was performed using Student's *t* test (\*, P ≤ 0.05). Similar results were obtained using a combination of neutralizing antibodies to IL-17A and IL-17F. Error bars are SEM.](JEM_20130904_Fig6){#fig6}

Concluding remarks
------------------

Our study demonstrates that Crtam is highly expressed on activated CD4^+^ and CD4^+^CD8^+^ T cells of the intestinal epithelium and more broadly expressed on activated CD8^+^ T cells of the intestinal mucosa, Peyer's Patches, and mLNs. Crtam is essential for residency of intraepithelial CD4^+^CD8^+^ T cells and is also partially required for mucosal CD8^+^ and CD4^+^ T cells under steady-state conditions. Crtam may mediate T cell residency by directly acting as an adhesion molecule that binds Cadm1 on gut CD103^+^ DCs. By strengthening adherence of T cells to CD103^+^ DCs, Crtam--Cadm1 interactions may also sustain exposure of T cells to RA and TGF-β, which induce acquisition of gut homing and adhesion molecules on T cells ([@bib7]; [@bib24]; [@bib40]). Moreover, because TGF-β and RA promote the conversion of CD4^+^ T cells into CD4^+^CD8^+^ T cells ([@bib26]; [@bib30]), Crtam--Cadm1 interactions may also facilitate this conversion. Consistent with this hypothesis, CD4^+^CD8^+^ T cells were strongly reduced in the intestinal epithelium of *Batf3*^−/−^ mice, which lack CD103^+^ DCs. Although we did not observe Cadm1 on intestinal epithelial cells, they may express low amounts of Cadm1 that, although not detectable with available tools, may help attract and hold T cells expressing Crtam within the epithelium, where they are exposed to TGF-β and RA produced by epithelial cells.

Our study also demonstrates that Crtam--Cadm1 interactions impact intestinal T cell responses during mucosal response against *T. gondii* infection. *Crtam*^−/−^ mice mounted a protective TH1 response as robust as WT mice, despite the reduction of CD4^+^CD8^+^ T cells and CD4^+^ T cells. However, *Crtam*^−/−^ mice had fewer TH17 cells than WT mice, which resulted in more efficient clearance of intestinal *T. gondii* infection. Antibody-mediated neutralization of IL-17A and IL-17F in WT mice confirmed that limiting IL-17 enhances the clearance of *T. gondii*. These results corroborate previous reports that IL-17 has deleterious effects on intestinal resistance to *T. gondii*, possibly by inducing recruitment and activation of neutrophils that damage the epithelial barrier ([@bib14]).

Because the differentiation of CD4^+^CD8^+^ T cells from CD4^+^ T cells skews CD4^+^ T cell cytokine production toward IFN-γ at the expense of IL-17 production ([@bib26]; [@bib30]), the relative depletion of TH17 cells in *Crtam*^−/−^ mice may reflect an ongoing replacement of lost CD4^+^CD8^+^ T cells. The selective impact of Crtam--Cadm1 interactions on intestinal TH17 during *T. gondii* infection may also depend on the dynamic equilibrium between newly formed T cells and their retention in the gut. Because *T. gondii* elicits a strong TH1 response, the robust generation of TH1 may be sufficient to compensate for the defective homing and retention of these cells in the intestine. Because of their low frequency during *T. gondii* infection, TH17 cells may be more affected by Crtam deficiency and defective maintenance in the gut. Further studies using more virulent *T. gondii* strains, such as ME-49, will further delineate the role of CRTAM in controlling intestinal inflammation. It is also possible that Crtam--Cadm1 interactions have more impact on TH17 than TH1 because TH1 cells express other adhesion molecules that compensate for lack of Crtam. Because T cells express multiple receptors for Nectins and Necls expressed in the gut, such as CD226, CD96, and Tigit ([@bib10]), it will be important to assess the contribution of these molecules to T cell residency in the steady state and during host responses to pathogens.

MATERIALS AND METHODS
=====================

### Generation of *Crtam*^−/−^ mice.

A targeting construct was designed to replace exon 1, which encodes the initial translation start site, with a floxed neomycin resistance cassette. The construct was electroporated into E14.1 (129P2Ola/Hsd) ES cells. One correctly targeted clone was injected into C57BL/6 blastocysts and chimeras bred to CMV-Cre tg mice to excise the neomycin resistance cassette. The *Crtam* mutation was backcrossed until the genetic background was \>99% C57BL/6, facilitated and confirmed by genome-wide SSLP typing at 10-cM intervals. Heterozygote mice were intercrossed to generate *Crtam*^−/−^ mice; homozygotes were born at the expected Mendelian frequency and were phenotypically normal. Both males and females were fertile and bred very similarly to C57BL/6 mice housed in the same room.

### Mice.

*Rag1*^−/−^ mice were obtained from The Jackson Laboratory. *Cadm1*^−/−^ mice were generated by A. Bradley (Wellcome Trust Sanger Institute, Hinxton, England, UK; [@bib39]) and were backcrossed onto a C57BL/6 background until \>99% C57BL/6, facilitated and confirmed by genome-wide SSLP typing at 10-cM intervals. *Crtam*^−/−^, *Cadm1*^−/−^, *Rag1*^−/−^, C57BL/6, and *Batf3*^−/−^ on a 129S6/SvEv background and 129S6/SvEv mice were bred in a pathogen-free facility at Washington University. Age- and sex-matched animals were used throughout the experiments. All animal experiments were conducted according to USA Public Health Service Policy of Humane Care and Use of Laboratory Animals. All protocols were approved by the Institutional Animal Care and Use Committee (School of Medicine, Washington University, St. Louis, MO).

### *T. gondii* infection.

The luciferase-expressing PRU-Luc-GFP type II of *T. gondii* strain was provided by J. Boothroyd (Stanford University, Palo Alto, CA). Tissue cysts were obtained from the brains of CD1 outbred mice (Charles River) after 3 mo of infection with 20 cysts by i.p. injection. Experimental mice were infected with 5 cysts of *T. gondii* PRU-Luc-GFP orally. Weight was monitored every 48 h for the first 20 d and twice a week until day 50. Parasite burden was analyzed by bioluminescence measurements. Mice were imaged every 48 h for 20 d by i.p. injection of 150 mg of luciferin D (Biosynth AG) per kilogram of body weight and using a Xenogen IVIS 100 (Caliper Life Sciences). Data were analyzed with the Living Image Software (Caliper Life Sciences) and is expressed in relative light units. Antibody blockade was performed using anti--IL-17A (clone 17F3; Bio X Cell), isotype control (clone MOPC-21, Bio X Cell), and, in some experiments, anti--IL-17A and anti--IL-17F antibodies (provided by W. Ouyen, Genentech, South San Francisco, CA). For those experiments, mice were injected i.p. with 350 µg antibodies at days −1, 5, and 10 of *T. gondii* infection.

### Tissue isolation, flow cytometry, and cell sorting.

Small intestine IELs, small intestine LPLs, and Peyer's Patches were prepared as described by [@bib20]. For flow cytometry, the following fluorophore-labeled mAbs were used: CD3 (145-2C11), CD8α (53--6.7), and CD69 (H1.2F3; all BD); CD4 (GK1.5), CD103 (2E7), and CCR9 (eBioCW-1.2; eBioscience); CD45 (30F11.1; Miltenyi Biotec); Crtam (Cr24.1; produced in our laboratory; [@bib3]); and Crtam (11--5; BioLegend). For assessing the expression of CRTAM ligands, we used a mouse CRTAM-human Fc fusion protein ([@bib3]) together with a mouse anti--human IgG (JDC-10; SouthernBiotech). Streptavidin conjugated to APC-Cy7 was from BD and streptavidin conjugated to APC was from Invitrogen. Samples were processed in a FACSCanto II (BD) and analyzed with FlowJo software (Tree Star). Flow cytometric cell sorting was performed using a FACSAria II (BD).

### T cell stimulation.

To detect Crtam expression cells were stimulated for 14 h with plate-bound anti-CD3 and anti-CD28, followed by surface staining for T cell markers and Crtam. For intracellular staining, cells were stimulated with PMA and Ionomycin for 4 h in the presence of Golgi Plug (BD). Surface staining was performed, followed by fixation and permeabilization (Cytofix/Cytoperm Plus kit; BD). Intracellular cytokine contents were determined using the mAbs IL-17A (eBio17B7; eBioscience) and IFN-γ (XMG1.2; BD).

### T cell adherence.

To analyze the percentage of loosely associated IEL fraction, we used a protocol recently described ([@bib42]). In brief, a gentle dissociation of the small intestine consisting of stirring at 400 rpm in HBSS for 20 min was performed to obtain the loosely attached IEL before two vigorous extractions of stirring at 800 rpm in HBSS+ DTT for 20 min. The percentage of loose IEL was calculated using the absolute numbers of CD4^+^ and CD4^+^CD8^+^ T cells obtained in the loose and tight IEL fractions from each mouse.

### Adoptive transfer.

Splenocytes from naive C57BL/6 (CD45.1) and *Crtam*^−/−^ (CD45.2) mice were obtained and T cells purified with the Pan T cell isolation kit II (Miltenyi Biotec) and mixed at a 1:1 ratio, which was confirmed by flow cytometry. 10^6^ cells were injected i.v. into *Rag1*^−/−^ mice. 8 wk after transfer, frequencies of CD45.1 versus CD45.2 CD4^+^ and CD4^+^CD8^+^ T cells were analyzed in the small intestine of recipient mice.

### In vitro T cell polarization.

LN CD4^+^ T cells from WT and *Crtam*^−/−^ mice were enriched using a CD4^+^ T cell isolation kit (Miltenyi Biotec). 2 × 10^5^ cells were activated with plate-bound anti-CD3 (10 µg/ml) and anti-CD28 (2 µg/ml) under polarizing TH1 conditions, i.e., recombinant IL-2 (PeproTech), mIL-12 (PeproTech), and anti--mouse IL-4 mAb (11B11), or TH17 conditions, i.e., recombinant mIL-6 (PeproTech), hTGFb, mIL-23, mAb anti-IL-4 (11B11), and anti--IFN-γ (RUGA2) for 5 d (primary stimulation). For the secondary stimulation, T cells were washed, counted, and 2 × 10^5^ cells were restimulated with plate-bound anti-CD3 (10 µg/ml) and anti-CD28 (2 µg/ml) without added cytokines or antibodies for 2 more days. Cells were analyzed for cytokine production by intracellular staining either after 5-d stimulation or 2-d restimulation. Supernatants were also collected at these times, and IFN-γ and IL-17 concentrations determined by cytometric bead array (BD).

### *C. rodentium* infection.

Experimental mice were made to fast for 8 h before intraoral inoculation of 2 × 10^9^ *C. rodentium* strain DBS100 (American Type Culture Collection). Survival was monitored for 21 d. Spleens were weighed and homogenized and serial dilutions were plated for 24 h at 37°C onto MacConkey agar plates for measurement of colony-forming units.

### RNA extraction and quantitative PCR.

RNA was extracted from cell-sorted populations of siIEL with an RNeasy micro kit and from ileum samples with an RNeasy Mini kit according to the manufacturer's recommendations (QIAGEN). cDNA was synthesized from RNA with Superscript III first-strand synthesis system for RT-PCR (Invitrogen). RNA expression was analyzed by quantitative PCR using SYBR Green PCR Master Mix (Bio-Rad Laboratories) and an ABI7000 (Applied Biosystems). The following oligonucleotides were used: Tgfb1 forward, 5′-TTGCTTCAGCTCCACAGAGA-3′; Tgfb1 reverse, 5′-TGGTTGTAGAGGGCAAGGAC-3′; Il10 forward, 5′-TGGCCTTGTAGACACCTTGG-3′; Il10 reverse, 5′-AGCTGAAGACCCTCAGGATG-3′; Il17a forward, 5′-AGAGCTGCCCCTTCACTTTC-3′; Il17a reverse, 5′-TGGGGGTTTCTTAGGGGTCA-3′; Il17f forward, 5′-CTGGAGGATAACACTGTGAGAGT-3′; Il17f reverse, 5′-TGCTGAATGGCGACGGAGTTC-3′; Il22 forward, 5′-GCTCAGCTCCTGTCACATCA-3′; Il22 reverse, 5′-AGCTTCTTCTCGCTCAGACG-3′; ifng forward, 5′-ACAATGAACGCTACACACTGCAT-3′; ifng reverse, 5′-TGGCAGTAACAGCCAGAAACA-3′; tbp forward, 5′-CCTTCACCAATGACTCCTATGAC-3′; and tbp reverse, 5′-CAAGTTTACAGCCAAGATTCAC-3′. The expression of target mRNA was calculated and normalized to the expression of the house keeping gene *tbp* (tata-box binding protein) using the 2^(−ΔΔCT)^ method.

### Expression microarray analysis.

CD4^+^ T cells (CD45^+^CD3^+^CD4^+^CD8α^−^) from the siIEL of WT and *Crtam*^−/−^ mice at day 8 after *T. gondii* infection were sorted. Total RNA was isolated from cells using RNeasy micro kit (QIAGEN). Mouse Gene 1.0 ST arrays were performed. RNA was amplified with the WT Expression kit (Invitrogen) and labeled, fragmented, and hybridized with the WT Terminal Labeling and Hybridization kit (Affymetrix). Data were processed using RMA (robust multichip average) quantile normalization, and expression values were modeled using ArrayStar software (DNASTAR).

### Statistical analysis.

All statistical analyses were performed with Prism 5.0 (GraphPad Software). Cell numbers were analyzed by Mann-Whitney test; all other data were analyzed with a nonpaired Student's *t* test. A p-value of \<0.05 was considered significant.

### Online supplemental material.

Figure S1 shows *Crtam*^−/−^ mice. Online supplemental material is available at <http://www.jem.org/cgi/content/full/jem.20130904/DC1>.
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